"Given the polarization
that currently exists across the country, it is striking how much agreement
there is on the idea that patients should be entitled to know the cost of a
medical procedure before they get treatment."
— Michael Abrams, co-founder of consultancy Numerof &
Associates, talked with AIS's Health
Plan Weekly about why the Biden administration might move forward
with CMS's final payer price transparency rule.
Subscribers may read the Health Plan Weekly article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment